STERIS’ (TSE:STE – Free Report) – Stock analysts at Cormark reduced their FY2025 EPS estimates for shares of STERIS’ in a research report issued on Monday, January 6th. Cormark analyst B. Watson now expects that the company will post earnings of $0.38 per share for the year, down from their previous estimate of $0.86. Cormark currently has a “Moderate Buy” rating on the stock.
Separately, Atb Cap Markets upgraded STERIS’ to a “strong-buy” rating in a report on Sunday, December 22nd.
STERIS’ Stock Performance
STERIS’ Company Profile
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Featured Stories
- Five stocks we like better than STERIS’
- How to Use the MarketBeat Dividend Calculator
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- Manufacturing Stocks Investing
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
